Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (101-110 of 466) with videos related to

Pageof 47
Sort By:
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
Blood|November 2, 2002
Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemiaMatthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, et al.
Haematologica|March 7, 2020
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 miceBola S Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, et al.
Haematologica|August 10, 2012
TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11qAngela Garding, Nupur Bhattacharya, Sarah Haebe, et al.
Blood|May 31, 2002
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genesChristian Korz, Armin Pscherer, Axel Benner, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
British Journal of Haematology|January 11, 2018
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practiceJohn G Gribben, Francesc Bosch, Florence Cymbalista, et al.
International Journal of Cancer|April 10, 2007
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemiaManfred Hensel, Martin Zoz, Christian Giesecke, et al.
Science Advances|September 12, 2025
CLL to Richter syndrome: Integrating network strategies with experiments elucidating disease drivers and personalized therapiesJulia Maier, Julian D Schwab, Silke D Werle, et al.
Pageof 47

Showing results (101-110 of 466) with videos related to

Sort By:
Pageof 47
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
Blood|November 2, 2002
Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemiaMatthias Ritgen, Alexandra Lange, Stephan Stilgenbauer, et al.
Haematologica|March 7, 2020
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 miceBola S Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, et al.
Haematologica|August 10, 2012
TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11qAngela Garding, Nupur Bhattacharya, Sarah Haebe, et al.
Blood|May 31, 2002
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genesChristian Korz, Armin Pscherer, Axel Benner, et al.
Haematologica|April 21, 2019
Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemiaEugen Tausch, William Close, Anna Dolnik, et al.
European Journal of Haematology|March 24, 2009
Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemiaChristian Geisler, Jesper Jurlander, Lars Bullinger, et al.
British Journal of Haematology|January 11, 2018
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practiceJohn G Gribben, Francesc Bosch, Florence Cymbalista, et al.
International Journal of Cancer|April 10, 2007
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemiaManfred Hensel, Martin Zoz, Christian Giesecke, et al.
Science Advances|September 12, 2025
CLL to Richter syndrome: Integrating network strategies with experiments elucidating disease drivers and personalized therapiesJulia Maier, Julian D Schwab, Silke D Werle, et al.
Pageof 47